Project Details
Short title | Phase II, Open Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma |
---|---|
Status | Finished |
Effective start/end date | 30/04/09 → 31/12/12 |
Funding
- Queen Elizabeth Hospital Birmingham